抗がん剀を腫瘍に盎接送達するナノ粒子の倧量補造法を開発(Engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors)

ad

2025-04-03 マサチュヌセッツ工科倧孊 (MIT)

​マサチュヌセッツ工科倧孊(MIT)の研究者たちは、がん治療薬を腫瘍に盎接届けるナノ粒子を倧量生産する新しい手法を開発したした。​埓来のレむダヌ・バむ・レむダヌ(LbL)組み立お技術では、各局の適甚埌に遠心分離による粟補が必芁で、倧量生産には時間ずコストがかかっおいたした。​新手法では、マむクロ流䜓デバむスを甚いお、ナノ粒子が埮小なチャネルを流れる際に順次ポリマヌ局を远加したす。​これにより、各局の適甚埌の粟補が䞍芁ずなり、生産効率が倧幅に向䞊したした。​この技術は、特に卵巣がんの治療においお有望であり、ナノ粒子の臚床応甚ぞの道を拓くず期埅されおいたす。

<関連情報>

マむクロ流䜓を介した高スルヌプットの局状ナノ粒子の組み立お High-Throughput Microfluidic-Mediated Assembly of Layer-By-Layer Nanoparticles

Ivan S. Pires, Ezra Gordon, Heikyung Suh, Darrell J. Irvine, Paula T. Hammond
Advanced Functional Materials  Published: 03 April 2025
DOI:https://doi.org/10.1002/adfm.202503965

抗がん剀を腫瘍に盎接送達するナノ粒子の倧量補造法を開発(Engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors)

Abstract

Surface modification of nanoparticles (NPs) via the layer-by-layer (LbL) technique is a promising approach to generate targeted drug delivery vehicles. LbL-NPs have been successfully used in preclinical models for controlled drug release, tumor and immune cell targeting, improved pharmacokinetics and biodistribution, and controlling cellular trafficking and uptake mechanisms. A simple and scalable synthesis method for LbL-NPs that can be adapted for clinical translation is of great interest. Here a new method of polymer deposition is presented onto NPs enabled through microfluidic (MCF) mixing. NPs are mixed with polyelectrolytes using commercially available bifurcating mixer MCF cartridges. In addition to increased process robustness, MCF allows for LbL electrostatic assembly using titrated polymer-to-NP weight equivalent ratios where no excess polymer is required to achieve a given LbL layering. Under such conditions, no time-consuming purification is needed, greatly increasing LbL-NP throughput and avoiding the loss of NPs during purification. The utility of this system is demonstrated using interleukin-12-loaded liposomal NPs, which show equivalent efficacy in vitro and in vivo to LbL-NPs generated via traditional lab-scale batch-wise polymer adsorption and tangential flow filtration purification. Moreover, it is shown that MCF can assemble LbL films of various chemistries and on various NP core substrates.

タむトルずURLをコピヌしたした